TD Private Client Wealth’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
TD Private Client Wealth's OGN Position: Q2 2025 in Review
TD Private Client Wealth sold out of Organon & Co (OGN) in Q2 2025, closing a stake of 401 shares — an estimated $5.97K sold.
TD Private Client Wealth first reported a position in OGN in Q2 2021 and held it in 15 quarters. The position peaked at $59.8K in Q3 2021. 695 funds tracked by Wall St. Rank hold OGN as of Q2 2025.
- TD Private Client Wealth reported no remaining Organon & Co position as of Q2 2025 after selling out during the quarter.
- TD Private Client Wealth sold 401 Organon & Co shares in Q2 2025, an estimated $5.97K.
- TD Private Client Wealth first reported a position in Organon & Co in Q2 2021 and held it in 15 quarters.
- TD Private Client Wealth's Organon & Co position peaked at $59.8K in Q3 2021.
- 695 funds tracked by Wall St. Rank held Organon & Co as of Q2 2025.
Based on TD Private Client Wealth's 13F filing for Q2 2025, filed 15 Jul 2025.